We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$138M
AUM Growth
+$3.81M
(+2.8%)
Cap. Flow
+$4.2M
Cap. Flow
% of AUM
3.03%
Top 10 Holdings %
Top 10 Hldgs %
35.89%
Holding
98
New
17
Increased
24
Reduced
4
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atea Pharmaceuticals
AVIR
|
+$2.7M |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$2.04M |
| 3 |
BP
BP
|
+$1.57M |
| 4 |
Intel
INTC
|
+$1.47M |
| 5 |
Citigroup
C
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
inTEST
INTT
|
+$2.95M |
| 2 |
Merck
MRK
|
+$1.85M |
| 3 |
Exelixis
EXEL
|
+$1.81M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
+$1.63M |
| 5 |
Energy Transfer Partners
ET
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.58% |
| 2 | Financials | 14.24% |
| 3 | Technology | 13.07% |
| 4 | Energy | 11.74% |
| 5 | Materials | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Femasys
FEMY
$11.2M
| $487K | 0.35% |
+3,000
| New | +$573K |
|
77
AMCON Distributing
DIT
$63.4M
| $472K | 0.34% |
4,625
+177
| +4% | +$15.9K |
|
78
Hewlett Packard
HPE
$63.2B
| $437K | 0.32% |
+30,000
| New | +$474K |
|
79
Fidelity National Financial
FNF
$13.9B
| $435K | 0.31% |
+10,400
| New | +$454K |
|
|
ARKOW
80
DELISTED
ARKO Corp Warrant
ARKOW
| $398K | 0.29% |
200,000
+50,000
| +33% | +$103K |
|
|
PTPI
81
DELISTED
Petros Pharmaceuticals
PTPI
| $313K | 0.23% |
400
+220
| +122% | +$176K |
|
82
Teva Pharmaceuticals
TEVA
$35.9B
| $248K | 0.18% |
25,000
| – | – |
|
83
Gain Therapeutics
GANX
$74.6M
| $100K | 0.07% |
+10,000
| New | +$113K |
|
|
TAOX
84
Tao Synergies Inc
TAOX
$24.6M
| $99K | 0.07% |
+400
| New | +$93.8K |
|
|
CRTDW
85
DELISTED
Creatd Inc. Warrant
CRTDW
| $37K | 0.03% |
22,383
+13,341
| +148% | +$24.4K |
|
86
Alkermes
ALKS
$8.82B
| – | – |
-70,000
| Closed | -$1.31M |
|
87
Amgen
AMGN
$203B
| – | – |
-5,000
| Closed | -$1.24M |
|
|
88
Energy Transfer Partners
ET
$70.1B
| – | – |
-200,000
| Closed | -$1.54M |
|
|
89
Exelixis
EXEL
$13.9B
| – | – |
-80,000
| Closed | -$1.81M |
|
90
Kraft Heinz
KHC
$30.4B
| – | – |
-30,000
| Closed | -$1.2M |
|
|
91
Merck
MRK
$324B
| – | – |
-25,152
| Closed | -$1.85M |
|
92
Prudential Financial
PRU
$41.7B
| – | – |
-12,000
| Closed | -$1.09M |
|
93
SiriusXM
SIRI
$10B
| – | – |
-20,000
| Closed | -$1.22M |
|
|
VTLE
94
DELISTED
Vital Energy
VTLE
| – | – |
-35,000
| Closed | -$1.05M |
|
|
SWN
95
DELISTED
Southwestern Energy Company
SWN
| – | – |
-350,000
| Closed | -$1.63M |
|
|
HGEN
96
DELISTED
HUMANIGEN, INC.
HGEN
| – | – |
-25,000
| Closed | -$478K |
|
|
CSOD
97
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| – | – |
-20,000
| Closed | -$872K |
|
|
UFS
98
DELISTED
DOMTAR CORPORATION (New)
UFS
| – | – |
-30,000
| Closed | -$1.11M |
|
Similar funds
CC
DG
ACM
WAG
BCWM
WF
SA
SRL
CM Management's Q2 2021 Portfolio in Review
As of Q2 2021, CM Management held 98 positions worth $138M, up 2.8% from $135M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
CM Management deployed $4.2M of net new capital in Q2 2021, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Atea Pharmaceuticals: 90,000 shares worth $1.93M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 41% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was inTEST, an estimated $2.95M trimmed.
- CM Management's largest Q2 2021 buy was Atea Pharmaceuticals: 90,000 shares worth $1.93M.
- CM Management added most to Coterra Energy in Q2 2021, an estimated $2.04M increase.
- CM Management's biggest Q2 2021 reduction was inTEST, cutting an estimated $2.95M.
- CM Management fully exited Merck in Q2 2021, selling an estimated $1.85M.
- CM Management's ten largest holdings make up 36% of its $138M portfolio in Q2 2021.
- CM Management opened 17 new positions and closed 13 in Q2 2021.
- CM Management's portfolio value rose 2.8% quarter-over-quarter to $138M.
Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.